Loading
A phase 2/3 trial of cisplatin in pancreatic cancer, run by Fudan University, now recruiting.
Cisplatin to Patients With Pancreatic Cancer and Homologous Recombination Deficiency is a phase 2/3, interventional study registered as NCT06095141 by Fudan University, with a registry enrolment figure of 30 participants, started 2023-12-01 and due to reach its primary completion in 2025-10-31. Interventions recorded: Cisplatin. Conditions listed: Pancreatic Adenocarcinoma; Homologous Recombination Deficiency. Primary outcome: progression-free survival, PFS. Pancreatic eligibility wording from the registry: "* Histologically or cytologically confirmed advanced pancreas adenocarcinoma". Sites: China. No results are recorded here; the registry entry is the source.
Shares Platinum agents, Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma, Cisplatin and the tag pancreatic-deep-dive.
Shares BRCA or PALB2-mutant pancreatic ductal adenocarcinoma, Platinum agents, Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares BRCA or PALB2-mutant pancreatic ductal adenocarcinoma, Platinum agents, Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Platinum agents, Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma, Cisplatin and the tag pancreatic-deep-dive.
Shares Platinum agents, Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma, Cisplatin and the tag pancreatic-deep-dive.
Shares BRCA or PALB2-mutant pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Platinum agents, Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma, Cisplatin and the tag pancreatic-deep-dive.
Shares Platinum agents, Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma, Cytotoxic chemotherapy and the tag pancreatic-deep-dive.